Search

everythinglearnresearchcommunity

for

Search:↓

Ipilimumab can cause various adverse events in elderly patients, especially affecting the gastrointestinal and endocrine systems.

Interferon α‐2b can temporarily reduce hepatitis C virus and normalize liver enzyme levels.

A 308 nm excimer laser successfully treated a boy with a rare skin condition after about a year of weekly sessions.

Patients with severe alopecia areata have higher levels of MIF, which decrease after successful treatment.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

Dupilumab improves skin microbiome balance in atopic dermatitis patients.

Tofacitinib may be an effective and safe treatment for adolescent alopecia areata.

A comprehensive approach to educating patients and managing side effects is crucial for improving adherence to multiple sclerosis treatments and patient quality of life.

Ocrelizumab may cause total body hair loss in some patients.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

Targeting NETs may help reduce fibrosis in Crohn's disease.

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.

Upadacitinib may effectively treat resistant lichen planopilaris.

Tofacitinib was found to be a safe and effective treatment for hair regrowth in patients with alopecia areata.

Systemic therapy may reduce male infertility in psoriasis patients.

Social media can help compare the effectiveness and safety of new arthritis medications.

Tofacitinib helped a woman with total-body hair loss grow her hair back.

Amivantamab can cause severe skin eruptions and scarring, requiring drug discontinuation and early treatment.

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Azathioprine caused side effects in over half of the Korean pediatric inflammatory bowel disease patients, requiring close monitoring.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

Tofacitinib is effective and safe for treating alopecia areata with a good drug survival rate.

Adipose stem cell exosomes can effectively reduce facial redness and improve skin health in atopic dermatitis patients.

Methotrexate reduced the need for steroids in asthma patients without worsening their condition.

Isotretinoin with tacrolimus may be more effective short-term for treating frontal fibrosing alopecia than finasteride with tacrolimus.

Recombinant thrombomodulin can effectively treat severe complications in Cronkhite-Canada syndrome.

Targeting MIG and MCP-1 may help treat inflammation in alopecia areata.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Tofacitinib is effective and safe for treating alopecia areata.